Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven prophylaxis against parenteral nutrition-associated cholestasis in infants
ChiCTR-TRC-08000717Phase 3Recruiting
- Sponsor
- Department of Paediatrics, Chinese University of Hong Kong
- Start
- Jan 1990
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in parenteral nutrition-associated cholestasis (PNAC) comparing Omegaven with Intralipid (2 arms). Primary endpoint: Development of parenteral nutrition-associated cholestasis. Started Jan 1990; status: recruiting.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acidIntralipid 10%
03
Conditions
parenteral nutrition-associated cholestasis (PNAC)
Beyond the preview
Go deeper on ChiCTR-TRC-08000717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000717.